Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors
PaperCitations, authors & open-access status
A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 253 citations, 2007 year and closed oa status.
253
Citations
2007
Year
closed
OA Status